[Therapeutic possibilities in metastatic cancer of the breast with hypercalcaemia. (Apropos of 2 cases)].
D015065:17-Hydroxycorticosteroids / Q000652:urine; D015068:17-Ketosteroids / Q000652:urine; D000328:Adult; D001859:Bone Neoplasms / Q000000981:diagnostic imaging / Q000188:drug therapy*; D001943:Breast Neoplasms; D002369:Castration; D003520:Cyclophosphamide / Q000627:therapeutic use; D004967:Estrogens / Q000652:urine; D005260:Female; D006801:Humans; D006934:Hypercalcemia / Q000209:etiology*; D008875:Middle Aged; D009362:Neoplasm Metastasis; D009640:Norethindrone / Q000008:administration & dosage; D010053:Ovary / Q000601:surgery; D010744:Phosphoric Monoester Hydrolases / Q000097:blood; D010758:Phosphorus / Q000097:blood; D011241:Prednisone / Q000008:administration & dosage; D011859:Radiography; D013739:Testosterone / Q000627:therapeutic use*
D015065:17-Hydroxycorticosteroids; D015068:17-Ketosteroids; D004967:Estrogens; D010758:Phosphorus; D013739:Testosterone; D003520:Cyclophosphamide; D010744:Phosphoric Monoester Hydrolases; D009640:Norethindrone; D011241:Prednisone
Les possibilités thérapeutiques dans les cancers du sein métastatiques avec hypercalcémie. (A propos de deux observations)